EBV reactivation and post transplant lymphoproliferative disorders following allogeneic SCT-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

EBV reactivation and post transplant lymphoproliferative disorders following allogeneic SCT

Published:2008-06-02 Issue:3 Volume:42 Page:181-186
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Ocheni S,Kroeger N,Zabelina T,Sobottka I,Ayuk F,Wolschke C,Muth A,Lellek H,Petersen L,Erttmann R,Kabisch H,Zander A R,Bacher U

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/bmt2008150.pdf

Reference27 articles.

1. Markasz L, Stuber G, Flaberg E, Jernberg AG, Eksborg S, Olah E et al. Cytotoxic drug sensitivity of Epstein–Barr virus transformed lymphoblastoid B-cells. BMC Cancer 2006; 6: 265.

2. Bower M . The management of lymphoma in the immunosuppressed patient. Best Pract Res Clin Haematol 2002; 15: 517–532.

3. Aalto SM, Juvonen E, Tarkkanen J, Volin L, Ruutu T, Mattila PS et al. Lymphoproliferative disease after allogeneic stem cell transplantation—pre-emptive diagnosis by quantification of Epstein–Barr virus DNA in serum. J Clin Virol 2003; 28: 275–283.

4. Juvonen E, Aalto SM, Tarkkanen J, Volin L, Mattila PS, Knuutila S et al. High incidence of PTLD after non-T-cell-depleted allogeneic haematopoietic stem cell transplantation as a consequence of intensive immunosuppressive treatment. Bone Marrow Transplant 2003; 32: 97–102.

5. Martin-Gomez MA, Pena M, Cabello M, Burgos D, Gutierrez C, Sola E et al. Posttransplant lymphoproliferative disease: a series of 23 cases. Transplant Proc 2006; 38: 2448–2450.

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tabelecleucel for EBV+ PTLD after allogeneic HCT or SOT in a multicenter expanded access protocol;Blood Advances;2024-06-12

2. Revealing the hidden interplay: The unexplored relationship between fungi and viruses beyond HIV, SARS-CoV-2, and influenza;Medical Mycology;2024-03-12

3. Adoptive cellular therapy after hematopoietic stem cell transplantation;American Journal of Hematology;2024-01-25

4. Immune dysregulation as a leading principle for lymphoma development in diverse immunological backgrounds;Immunology Letters;2023-11

5. Expert Consensus on the Characteristics of Patients with Epstein–Barr Virus-Positive Post-Transplant Lymphoproliferative Disease (EBV+ PTLD) for Whom Standard-Dose Chemotherapy May be Inappropriate: A Modified Delphi Study;Advances in Therapy;2023-01-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3